Pediatrics
Feature
Repurposed drug could revolutionize stem cell transplantation
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
Latest News
Pediatric IBD increases cancer risk later in life
Overall, the risk for cancer among individuals with pediatric-onset IBD was 2.4-fold higher than that of their peers without IBD.
Latest News
Pediatrics group stresses benefits of vitamin K shots for infants
Infants who do not receive vitamin K at birth are 81 times more likely to develop late-onset vitamin K deficiency bleeding, which occurs a week to...
News
FDA delays action on Pfizer vaccine for kids under 5
“At this time it makes sense for us to wait until we have the data of the evaluation of a third dose before taking action.”
From the Journals
Endometriosis not linked with preterm birth, new study finds
Changing monitoring strategies to prevent preterm birth for women with the disease may not be necessary.
From the Journals
Global pediatric oncology workforce hit hard, but resilient amid pandemic
Half of participating institutions experienced staffing shortages that had a “major impact” on pediatric cancer care.
Feature
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
Feature
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
News
COVID-19 linked to increased diabetes risk in youth
Two large databases indicate significantly increased diabetes risk among those with COVID-19 but not other acute respiratory illnesses.
News from the FDA/CDC
Voxelotor for sickle cell anemia now down to 4-year-olds
Conference Coverage
Fitusiran: Great ‘leap forward’ in hemophilia treatment
Cost will be a major consideration if fitusiran is approved for the U.S. market.